After finding no evidence that the KRAS–BRAF pathway directly activates ERK5, authors showed that, at a concentration where ERK5 activity was almost completely inhibited, BIX02189 had no effect on cancer cell proliferation. The gene discussed is MAPK7; the disease is cancer.